Mirae Asset Global Investments’s Asensus Surgical, Inc. ASXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-280,594
Closed -$152K 1557
2020
Q2
$152K Buy
280,594
+17,718
+7% +$8.55K ﹤0.01% 1420
2020
Q1
$92K Sell
262,876
-36,326
-12% -$37.9K ﹤0.01% 1378
2019
Q4
$440K Sell
299,202
-18,882
-6% -$65.6K ﹤0.01% 1251
2019
Q3
$2.56M Sell
318,084
-4,900
-2% -$66.6K 0.02% 642
2019
Q2
$5.71M Sell
322,984
-5,774
-2% -$126K 0.04% 427
2019
Q1
$10.2M Sell
328,758
-6,281
-2% -$211K 0.07% 255
2018
Q4
$9.84M Sell
335,039
-64,742
-16% -$2.94M 0.09% 237
2018
Q3
$30.1M Buy
+399,781
New +$27.1M 0.22% 102

Other funds holding ASXC

Mirae Asset Global Investments's ASXC Position: Q3 2020 in Review

Mirae Asset Global Investments sold out of Asensus Surgical, Inc. (ASXC) in Q3 2020, closing a stake of 280,594 shares — an estimated $152K sold.

Mirae Asset Global Investments first reported a position in ASXC in Q3 2018 and held it in 8 quarters. The position peaked at $30.1M in Q3 2018. 67 funds tracked by Wall St. Rank hold ASXC as of Q3 2020.

  • Mirae Asset Global Investments reported no remaining Asensus Surgical, Inc. position as of Q3 2020 after selling out during the quarter.
  • Mirae Asset Global Investments sold 280,594 Asensus Surgical, Inc. shares in Q3 2020, an estimated $152K.
  • Mirae Asset Global Investments first reported a position in Asensus Surgical, Inc. in Q3 2018 and held it in 8 quarters.
  • Mirae Asset Global Investments's Asensus Surgical, Inc. position peaked at $30.1M in Q3 2018.
  • 67 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2020.

Based on Mirae Asset Global Investments's 13F filing for Q3 2020, filed 12 Nov 2020.